Session 5: New pathways with potential impact in the treatment of early breast cancer
Chairs: Masazaku Toi (Japan), Jiang Zefei (China)
- Targeting DNA repair (Andrew Tutt, UK)
- Targeting the CDK 4‐6 pathway (Nicholas Turner, UK)
- Targeting immune pathway (Sherene Loi, Australia)
- How the recent data from metastatic trials inform us on treatment opportunities for patients with early breast cancer? (Fatima Cardoso, Portugal)
BCC2019 PARTICIPANT: PASSWORD in BCC e-mail from March 23.